FDA Orange Book
Is there a generic for Airsupra?
Airsupra contains albuterol and budesonide. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
No. The Orange Book lists no active FDA-approved generic (ANDA) for Airsupra (albuterol and budesonide). The Orange Book shows its last listed patent expires May 28, 2030 and its last listed exclusivity ends September 15, 2028.
Run it in Rivvi
Map Airsupra and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Airsupra products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| aerosol, metered, inhalation | EQ 0.09MG BASE/INH;0.08MG/INH | Marketed (Rx) | None | 0 | None |
NDA 214070, held by ASTRAZENECA PHARMACEUTICALS LP. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Airsupra patents
| Patent | Expires | Covers | Use code | NDA |
|---|---|---|---|---|
| 9415009 | May 28, 2030 | Method of use | U-3509 | 214070 |
Airsupra exclusivity
| Code | Meaning | Expires | NDA |
|---|---|---|---|
| NP | New product | January 10, 2026 | 214070 |
| M-317 | Miscellaneous | September 15, 2028 | 214070 |
Airsupra NDC codes
Questions
Is there a generic for Airsupra?
No. The Orange Book lists no active FDA-approved generic (ANDA) for Airsupra (albuterol and budesonide). The Orange Book shows its last listed patent expires May 28, 2030 and its last listed exclusivity ends September 15, 2028.
What is the generic name for Airsupra?
The active ingredient in Airsupra is albuterol and budesonide, per the FDA Orange Book.
When does the Airsupra patent expire?
The last patent listed for Airsupra in the Orange Book expires May 28, 2030. A listed patent expiry date is not a generic launch date.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.